期刊文献+

康莱特联合化疗治疗中晚期非小细胞肺癌 被引量:17

Combination of GP regimen and Kanglaite in the treatment of advanced non-small cell lung cancer
下载PDF
导出
摘要 背景与目的 化疗是中晚期非小细胞肺癌常用的治疗方法,但化疗有效率较低,约20%~50%,而且存在较为严重的副作用。为提高疗效,改善患者生活质量,降低毒副反应,本研究对康莱特联合化疗和单纯化疗治疗中晚期非小细胞肺癌的疗效、毒副反应及对生存质量的影响进行了比较。方法 将100例患者随机分成两组。单纯化疗组(对照组)50例,采用GP方案:吉西他滨1000mg/m^3,第1、8天,顺铂80mg/m^3,第2天,3周为一周期。康莱特联合化疗组(康莱特组)50例,化疗方案同对照组,于每周期化疗第一天开始静脉滴注10%康莱特注射液200ml,连用10天。两周期治疗结束后对其近期疗效、毒副反应及生存质量进行评价。结果 康莱特组有效率为52%,对照组为32%,两组比较有显著性差异(X^2-4.04,P〈0.05)。两组疗后的生存质量有显著性差异(t=2.8,P〈0.05)。康莱特组的不良反应发生率低于对照组,且发生的程度较轻。结论 康莱特联合化疗能提高有效率,降低不良反应,改善患者的生存质量。 Background and objective Chemotherapy is a common way to treat advanced non-small cell lung cancer (NSCLC). The response rate of chemotherapy is only 20 %-50%, and the side effects are serious. To improve efficacy and quality of life and to reduce side effects of chemotherapy become main tasks of clinical researches. The aim of this study is to evaluate GP regimen alone and GP regimen combined with Kanglaite on the efficacy, side effects and the improvement of quality of life in the treatment of advanced NSCLC. Methods Randomly fifty patients with NSCLC in stage Ⅲ and Ⅳ were treated by GP regimen combining with Kanglaite, and fifty patients were treated with GP regimen alone. Kanglaite was used on the first day of each chemotherapy cycle for consecutive 10 days, and the dosage was 200 ml/d. GP regimen included gemcitabine 1000 mg/m^2 on 1st and 8th days and cisplatin 80 mg/m^2 on 2nd day. The treatment was repeated every three weeks. The efficacy, side effect and quality of life were compared after two cycles of chemotherapy. Results Response rate was 52% in combining group and 32% in control group. The rates were different between the two groups (X^2 =4.04, P〈0.05). Quality of life in combining group was significantly higher than that in control :group after treatment (t=2.8, P〈0.05). The incidence of side effects in combining group was lower than that in control group, and the degree was also slighter. Conclusion Kanglaite in combination with GP regimen can be used for the treatment of advanced NSCLC. It can improve efficacy and the quality of life, and reduce the side effect of chemotherapy.
出处 《中国肺癌杂志》 CAS 2006年第1期74-77,共4页 Chinese Journal of Lung Cancer
关键词 康莱特 联合化疗 非小细胞肺癌 Kanglaite Comprehensive chemotherapy Non-small cell lung cancer
  • 相关文献

参考文献7

二级参考文献25

  • 1潘启超.长春碱类的新进展──失碳长春碱[J].癌症,1996,15(3):228-231. 被引量:276
  • 2李大鹏.康莱特注射液治疗原发性肺癌临床报告[J].中医杂志,1996,37(7):411-414. 被引量:66
  • 3中国人民解放军总后勤部卫生部.临床疾病诊断依据治愈好转标准[M].人民军医出版社,1998.281.
  • 4张鲁榕.流式细胞仪分析100例正常成人T细胞亚群[J].上海免疫学杂志,1988,8(5):367-367.
  • 5徐文昌 吴善芳 等.肺癌[M].上海:上海科学技术出版社,1993.220-220.
  • 6刘春安 彭明.抗肿瘤中草药大词典[M].武汉:湖北科学技术出版社,1994.1121-1122.
  • 7[2]中国抗癌协会编新编常见恶性肿瘤治疗规范[M].北京:北京医科大学,中国协和医科大学联合出版社,1999.53
  • 8[1]Mountain CF.Revisions in the international system for staging lung cancer[J].Chest J,1997,111(6):1710.
  • 9[4]Goldie JH.Scientific basis for adjuvant and primary (neoadjuva nt)chemotherapy[J].Semin Oncol,1987,14(1):1.
  • 10[1]Socinski MA, Morris DE, Masters GA, et al. Chemotherapeutic management of stage Ⅳ non-small-cell lung cancer. Chest,2003, 123 (1 Suppl) :226

共引文献73

同被引文献268

引证文献17

二级引证文献202

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部